Table 1.
Design Constraints and Preparation Parameters in Shape Control for Different Nanoparticle Preparation Methods
| Nanoparticle Preparation Method | Shapes Prepared | Range of Aspect Ratio | Polymers† | Cargos | |
|---|---|---|---|---|---|
| Lithography | Rods, Cylinders, Cubes, Filamentous 14, 15, 18, 19 | 1 – 60 18, 19 | Polyethylene glycol, poly(lactic acid), poly(lactic acid-co- glycolic acid), proteins 15, 20, 21, 24 | Small molecule drugs, contrast agents, siRNA 17, 21, 25 | |
| S-FIL | Disks, Rods, Squares, Triangles 28–30 | 1 – 8 28, 29 | Polyethylene glycol 28, 29 | Antibodies, nucleic acids, small molecule drugs 28, 30 | |
| Membrane stretching | Rods, Disks, Ellipsoids, Pills, Barrels, Bullets, Lenses 32, 33, 35 | 1.5 – 15 32, 37, 38 | Polystyrene, poly(lactic acid-co- glycolic acid) 33, 35, 38 | Antibodies, small molecule drugs 32, 35, 38 | |
| Self assembly | Amphiphilic copolymers | Spheres, Rods, Filamentous, Vesicles, Toroids, Disks 43–45, 65, 88 | 1 – >100 44, 65, 88 | Polyethylene-block-polyethylene glycol, polycaprolactone-block- polyethylene glycol, poly(lactic acid-co-glycolic acid)- polyethylene glycol, poly(lactic acid)-block-polyethylene glycol, polystyrene-block-poly(acrylic acid) 39, 42, 44, 47, 65, 88 | Hydrophobic drugs loaded in the core 65, 66, 129 |
| Nucleic acid base-pairing | Cages, Polyhedrons, Nanotubes 92, 95, 96, 106 | 1 – 7 92, 95, 106 | Single-stranded DNA 92, 97 | Imaging agents, small molecule drugs, siRNA, proteins 102–106 | |
| Complex core micelles | Spheres, Rods, Worms 120–122, 125, 126 | 1 – 30 122, 125, 126 | Polyphosphoramidate-block- polyethylene glycol, linear polyethylenimine-graft- polyethylene glycol, poly(glutamic acid)-block-polyethylene glycol, polylysine-block-polyethylene glycol 5, 115, 116, 125, 126 | Nucleic acids 5, 116, 125 | |